We advise companies on how best to capitalise on, defend and co-operate based on their patent-protected innovations.
Our advisers act on domestic and international projects of all shapes and sizes, working with many of the leading names across this diverse sector. Browse our experience below, or use the filters to look-up recent work in particular geographies and legal disciplines.
Teva Pharmaceutical
Acted for Teva who initiated a claim for revocation of Gilead's Supplementary Protection Certificate ('SPC') for Truvada®, a dual combination product containing tenofovir disoproxil and emtricitibine, for the treatment of HIV. Following trial in December 2016, Mr Justice Arnold referred a question to the Court of Justice of the European Union in relation to what the criteria are for deciding whether the product is protected by a basic patent in force under Article 3(a) of the SPC Regulation.
Advised and litigated on behalf of Teva Pharmaceutical Industries, a leading global pharmaceutical company, on regulatory and patent matters concerning the launch of dimethyl fumarate in the Netherlands.
Advising Sandoz AG on interim injunction proceedings, and patent revocation and infringement proceedings following the launch in the UK of its generic dapagliflozin product.
Advised Sandoz AG, a global generics and biosimilars manufacturer, on revocation proceedings before the UK Patents Court concerning a dosing regime patent for Rivaroxaban (Xarelto), and on the subsequent damages enquiry arising from a wrongly granted interim injunction.
Advised Dana Fabre, a pharmaceutical company, on its appeal against a UK IPO decision refusing a paediatric extension to its SPCs protecting Tecentriq and Bavencio.
Advised Torrent, a leading pharmaceutical company, on patent litigation against Sanofi related to teriflunomide.
Representing Accord in revocation proceedings before the UK Patents Court concerning a patent protecting a subcutaneous formulation of Herceptin (trastuzumab) the blockbuster breast cancer drug.
Advising global pharmaceutical companies on regulatory matters, including marketing authorisation filing for fixed-dose combination products, interpretation of the Centralised Procedure framework, and strategic carve outs of indications or safety features from applications due to patent rights.
Acting for Safran Seats in patent litigation arising out of a patent infringement action commenced by Lufthansa Technik AG against Astronics AES, Panasonic Avionics Corp and Safran. The patent in issue concerns a safety device used in electrical systems in commercial aircraft.
Assisting a biotechnology company with patent litigation relating to patent entitlement issues in the field of functional plant-based proteins
Our expertise, at your disposal
With over 490 partners and 3000 people around the world, we are well-placed to support you across a full range of legal and advisory services.
Partner, Co-Head of Intellectual Property
EmailJudith is a patent specialist having over 20 years of experience in complex multijurisdictional patent litigation as well as extensive experience in pharma regulatory matters and transactional life sciences. Judith is also one of the firms Unified Patent Court Representatives.
Partner
EmailVirginia has in-depth experience on contentious and non contentious intellectual property and unfair competition matters, with a strong focus on pan-European patent litigation in an extensive range of sectors.
Partner
EmailCatherine is a patent and regulatory Life sciences & health specialist with a degree in pathology. She is based in the London, Dublin, and Belfast offices.
Partner
EmailKaren advises on Intellectual Property, Commercial Litigation, AI, Data, and Life Sciences regulation. She handles complex patent and brand litigation, and guides clients on IP commercialisation, EU AI Act compliance, advertising, data protection, FOI law, and medicines regulation.
Partner
EmailMark advises clients on patent disputes across a range of sectors including ICT, infrastructure and advanced manufacturing. Mark has successfully represented clients before the UK Courts at all levels and in arbitration as well as in various IP related mediations.
Partner
EmailJames has experience in Intellectual Property, with a focus on patent litigation in the telecommunications, life sciences and pharmaceutical fields. His expertise includes FRAND disputes, patent and IP licensing, misuse of confidential information and IP licence disputes.
Partner
EmailGareth advises life sciences clients on all exclusivity rights around pharmaceuticals and medical device products. Whether it is patents, SPCs or regulatory exclusivities, Gareth has decades of experience advising on these rights and has litigated in UK and EU courts.
Partner
EmailFred is a UK and European Patent Attorney and European Patent Litigator (UPC Representative) specialising in patent litigation, oppositions, prosecution, SPCs and risk advisory services for the chemistry and life sciences sector.
Partner
EmailTracey is an intellectual property litigator in the life sciences sector, who studied Natural Sciences specialising in pathology. Tracey's principal expertise is in leading high-profile, multi-jurisdictional patent cases where she coordinates litigation strategy across Europe and worldwide, acting for both innovator and generic/biosimilar clients.
Orbital has built specific workflows for Scottish commercial real estate work, built around Scots Law and Scottish real estate practice
Multinational law firm Pinsent Masons has advised Penta Real Estate on its investment into a landmark £230 million-plus joint venture with Staycity Group and advised the joint venture on the financing arrangements for the development, which will deliver a 350-room Wilde aparthotel in the heart of London's Farringdon district.
Multinational law firm Pinsent Masons has advised manufacturing companies PROXMUS and Promus on the sale of their businesses to CGH Innovation, one of Europe’s leading manufacturers of steel tanks and a portfolio company of H.I.G. Capital, a global private equity firm headquartered in Miami.
Judith Krens
Partner, Co-Head of Intellectual Property